We examined the topography and degree of cell loss within neurofibrillary tangles was also evaluated within these structures. Despite significant subcortical neurobasal ganglia structures commonly involved in progressive supranuclear palsy in order to identify any relationship fibrillary tangle formation in all cases, there was considerable variability in the degree of neuronal cell loss between degeneration in these nuclei and gaze palsy. Serial section analyses and unbiased quantitative techniques were in all basal ganglia regions, except the SNc which was consistently affected. There was no correlation between the applied to brain tissue from six cases with progressive supranuclear palsy (four with gaze palsy and two without) ranked density of neurofibrillary tangles and the degree of neuronal cell loss in any basal ganglia region. Comparisons and six controls with no neurological or neuropathological abnormalities. The total number of nucleolated neurons between cases with and without gaze palsy revealed a 40% greater decrease in the number of SNr neurons in cases within the substantia nigra pars compacta (SNc) and reticulata (SNr), the subthalamic nucleus, and the internal with gaze palsy (75 Ϯ 8% loss) compared with those without (35 Ϯ 14% loss). This was the largest difference between and external segments of the globus pallidus was determined for all subjects and the data expressed as these cases. As the SNr projects to the superior colliculus, degeneration of this basal ganglia structure may disrupt percentages of control values to compare degeneration across these basal ganglia structures. The density of eye movements in progressive supranuclear palsy.
Introduction
Progressive supranuclear palsy (PSP) is named after its most afferent control from the superior colliculi (Goldberg et al., 1991; Büttner-Ennever and Horn, 1997) , where, in PSP, some distinctive clinical sign, vertical supranuclear gaze palsy. Despite this, eye movements are usually normal at neurons have reduced choline acetyltransferase (Juncos et al., 1991) and neurofibrillary tangles (Daniel et al., 1995) . presentation and gaze palsy is occasionally absent throughout the disease (Litvan et al., 1996b; Santacruz et al., 1998) .
However, PSP cases with and without gaze palsies are not distinguished by these pathologies (Daniel et al., 1995) . Progressive degeneration of supranuclear oculomotor pathways in the brainstem is thought to underlie this sign Motor commands from the frontal cortex influence this system via a direct projection as well as through the basal (Daniel et al., 1995; Litvan, 1998) . Immunohistochemical evaluation of the burst neurons in the rostral interstitial ganglia (Goldberg et al., 1991; Stell and Bronstein, 1994; Büttner-Ennever and Horn, 1997; Sharpe, 1998 ). nucleus of the medial longitudinal fasciculus in three cases (Juncos et al., 1991) suggested that these neurons regulating
To meet criteria for the neuropathological diagnosis of PSP (Litvan et al., 1996a) , abundant pathology must be vertical gaze are significantly affected. Direct evaluation of the omnipause neurons in the pontine raphe interpositus show present in three of the four following brain regions: pons, pallidum, subthalamus and substantia nigra, but most an average 35% loss of these gating neurons for vertical gaze in cases with gaze palsy compared with those without (Revesz commonly in the latter three basal ganglia structures (Agid et al., 1987; Daniel et al., 1995; Verny et al., 1996) . . These burst and omnipause neurons receive greatest density of pathology is found in the basal ganglia substance P (MAS055, Seralab, Leicestershire, UK; diluted 1 : 1000), encephalin (MAS083, Seralab; diluted 1 : 500) and (Agid et al., 1987; Daniel et al., 1995; Feany et al., 1996; Litvan et al., 1996a; Verny et al., 1996) , these regions might parvalbumin (P3171, Sigma; diluted 1 : 10 000) for the delineation of the basal ganglia structures, as described previbe expected to be involved in the major clinical symptoms and signs of the disease. However, there have been no studies ously (Hardman et al., 1997a, b; Hardman and Halliday, 1999a, b) . Peroxidase visualization was used for the immunohistoevaluating the relationship between the degree of cell loss in basal ganglia structures and gaze palsy in PSP. The aim of chemistry (Halliday et al., 1995; Hardman et al., 1997b) . For this study, standardized pathological diagnostic the present study is to determine whether the presence of gaze palsy correlates with the site and extent of basal ganglia procedures were applied (Feany and Dickson, 1995; Litvan et al., 1996a) . Microscopic examination was performed on neuronal loss in six patients with pathologically confirmed diagnosis of PSP, four cases with and two cases without the sections prepared for quantitation as well as representative areas sampled in a standardized way. Samples of the precentral gaze palsy.
gyrus [Brodmann area (BA) 
Case selection
The neuropathology and clinical features of the cases analysed oblongata were paraffin-embedded, sectioned at 10 µm and stained using the same staining protocols as those in the present study have been described previously (Hardman et al., 1997a, b; Hardman and Halliday, 1999a, b and Braak, 1991; Mirra et al., 1991) . Six age-matched controls (cases free from neurological and neuropathological brainstem were separated from the cerebrum and the volume of the cerebrum determined. The length of each hemisphere disease) were selected for comparison as published previously (Hardman et al., 1997a, b; Hardman and Halliday, 1999a, b) . and the length of the brainstem were measured prior to being embedded in 3% agar in a square mould with the longest anteroposterior axis square to the mould surfaces. Thin slices, in the coronal plane for the cerebrum or the transverse plane
Clinical evaluations
Each case was prospectively studied by a neurologist, from for the brainstem, were cut using a rotary slicer. For each case the mean slice thickness was determined by dividing presentation until death, with detailed records of history, as well as physical and mental examination. Data from clinical the lengths measured by the number of slices cut. The average slice thickness for the cases examined was 3.35 mm (SD ϭ records and standardized forms were used to assess the following clinical features: bradykinesia and rigidity, rest 0.25 mm).
Tissue preparation has been previously described in detail tremor, levodopa response, early falls, eye movement abnormalities and dementia. Early falls were defined as (Hardman et al., 1997a, b) . For the cellular quantitation, coronal blocks of the basal ganglia and transverse slices of the occurring within the first 3 years of clinical disease onset. All cases received at least one standardized assessment. midbrain were cryoprotected in 30% sucrose solution prior to freezing on a cryostat and serially sectioned at 50 µm. The All six PSP cases exhibited bilateral limb bradykinesia and rigidity as well as unsteadiness of gait with associated accuracy of the cryostat to cut sections at 50 µm was evaluated by dividing the known thickness of the slice (see above) by falls. Prior to death, four of the six cases were either completely immobile or unable to stand unassisted. The the number of sections cut from each slice (average section thickness 50 µm, SD ϭ 0.5 µm). The serially cut sections were remaining two cases (cases 4 and 6) were still independently mobile but were experiencing frequent falls. The duration of arranged into 15 sequential series (sections spaced 750 µm apart). Sections from the first series were mounted on to slides gait instability with falls varied considerably between PSP cases (mean 3.7 years, range 1-12 years; Table 1 ). Four PSP and stained with cresyl violet for anatomical localization and cellular quantitation. Subsequent series of sections were cases (cases 1, 2, 3 and 5) developed supranuclear gaze palsy during life. In contrast to falls, the duration of gaze palsy stained with haematoxylin/eosin, modified Bielschowsky silver and immunohistochemistry using several antibodies: tau was relatively constant (mean 3.5 years, range 3-5 years; Table 1 ). Preceding death, the severity of eye movement II (T5530, Sigma, St Louis, Mo., USA; diluted 1 : 10 000) and ubiquitin (Z0458, Dako, Glostrup, Denmark; diluted 1 : 200) disorder ranged from moderate limitation of voluntary vertical saccades and pursuit eye movements (cases 1 and 5) to both counterstained with cresyl violet, GFAP (Z334, Dako; diluted 1 : 500) counterstained with luxol fast blue, as well as complete loss of all eye movements (case 2). Clinical dementia was absent in all six PSP cases as assessed using Colchester, Vt., USA) and then superimposed on the sections undergoing analysis through a camera lucida. the Clinical Dementia Rating Scale (Hughes et al., 1982) .
Neuronal loss within the SNc was analysed using an areal fractionator technique, as previously published (Hardman et al., 1997a) . Briefly, for each case a transverse section Quantitation of basal ganglia neurofibrillary through the midbrain at the level of the exiting third nerve tangles and cell loss fibres was taken and stained with cresyl violet. This level Basal ganglia nuclei where the neuropathological changes was chosen as it contains the most consistent sample of the are known to be maximal in PSP (Daniel et al., 1995;  largest number of SNc cell groups in transverse midbrain Litvan et al., 1996a; Verny et al., 1996) were selected for sections . Using Neurolucida software quantitation: the substantia nigra pars compacta (SNc) and the cross-sectional area of individual pigmented SNc cell pars reticulata (SNr), the internal (GPi) and external (GPe) clusters was calculated (Ͻ2% variation on repeated segments of the globus pallidus, and the subthalamic nucleus measures). For each cell cluster a central sample of neurons (STN). The substantia nigra was identified as a convex discwas point counted within a 10 ϫ 10 eye-piece graticule at shaped structure located within the ventrolateral portion of 400ϫ magnification giving the cellular areal fraction occupied the midbrain tegmentum directly dorsomedial to the cerebral by the pigmented neurons (Ͻ10% variation with multiple peduncles. It was subdivided into a more dorsally located grid placements). The cellular areal fraction was multiplied dopaminergic and pigmented SNc and a more ventrorostrally by the cross-sectional area of the cell cluster to give the located GABAergic SNr. The globus pallidus was identified overall cell area within each cluster and these values summed as a wedge-shaped structure ventrolateral to the internal to give the total area occupied by pigmented dopaminergic capsule, dorsolateral to the optic chiasm and tract, and neurons for each case. The value for each case is expressed as medial to the external medullary lamina and putamen. It the percentage of the mean control value (control SD ϭ 13%). was segmented posteriorly into the small, medially located A fractionator technique was used to quantify neuronal GABAergic GPi and the large, laterally located GABAergic loss in all other basal ganglia nuclei, as previously described GPe. The substantia nigra and GPi were defined by their (Hardman et al., 1997a, b; Hardman and Halliday, 1999a, b) . dense substance P innervation from the caudate and putamen, Because of the variations in the size and anatomical boundaries as previously described  of each region within the sections, the sampling for each Hardman and Halliday, 1999b) . The GPe was defined by its region varied. For the smallest structure (SNr), every 15th dense encephalin innervation from the caudate and putamen, section was used for the estimation of neuronal number as described previously (Hardman and Halliday, 1999a) . The (every 50 µm Nissl-stained section spaced 750 µm apart) STN was identified as a ventromedial to dorsolaterally while every 60th section was used for the largest structure oriented disc-shaped structure located ventrolateral to the (GPe) (every fourth Nissl-stained section spaced 3 mm apart). diencephalon, dorsolateral to the internal capsule and rostral For the GPi and STN, every 30th section was sampled (every to the substantia nigra. The STN was defined by its dense second Nissl-stained section spaced 1.5 mm apart). Estimates staining for the calcium binding protein parvalbumin, as of the total number of neurons for each region were calculated described previously (Hardman et al., 1997b) . The anatomical by multiplying the total number of nucleolated neurons boundaries for each region were plotted using a microscope/ counted within the samples by the reciprocal of the fraction sampled. The value for each case is expressed as the computer analysis system (Neurolucida, MicroBrightField, Fig. 1 Comparison of the tau pathology in the GPi of cases 6 (A) and 4 (B). In the present study, case 4 had the most extensive tau pathology while case 6 had the least. In both cases extensive tau-positive glia (open arrowheads) and neurofibrillary tangles (arrows) were found, consistent with a diagnosis of PSP. Occasional neurons were filled with tau-immunoreactivity (closed arrowheads), with some apparently devoid of tangle formation (A) while others had additional fibrillar condensation (B).
percentage of the mean control value (control SNr SD ϭ of neurofibrillary tangles was quantified to obtain a severity index on a four level scale (at 200ϫ magnification): 0 ϭ 7%, GPi SD ϭ 11%, GPe SD ϭ 11%, STN SD ϭ 7%).
Both the modified Bielschowsky silver stained sections as absent, ϩ ϭ one or two neurofibrillary tangles, ϩϩ ϭ two to five neurofibrillary tangles, ϩϩϩ ϭ six or more well as the sections immunoreactive for tau II were used to grade the degree of neurofibrillary pathology in the basal neurofibrillary tangles. Both staining protocols gave equivalent scores for each case. Spearman rank correlations ganglia, as previously described (Verny et al., 1996) . The neurofibrillary tangles in the basal ganglia have a distinctive were used to identify any relationship between the density of neurofibrillary tangles and the degree of neuronal cell globose shape which is easily differentiated from the prevalent small, irregularly-shaped glial inclusions (Fig. 1) . The density loss, and P values of Ͻ0.05 accepted as significant. Mean control values and the standard deviation are given for comparison. For most cases these values have been published previously (Hardman et al., 1997a, b; Hardman and Halliday, 1999a, b) . *An areal fractionator technique was used to determine the degree of neurodegeneration in the SNc. This technique gives the proportional cell area occupied by pigmented dopaminergic neurons rather than the estimated number of neurons. For all other basal ganglia nuclei a numerical fractionator technique was used to estimate the total number of neurons.
Fig. 2
Graph of the proportional reduction in neuronal number in each of the basal ganglia regions evaluated in PSP cases with and without gaze palsy. The number of neurons in each basal ganglia region is expressed as a percentage of the control mean for each region (control SNc SD ϭ 13%, SNr SD ϭ 7%, GPi SD ϭ 11%, GPe SD ϭ 11%, STN SD ϭ 7%). With the exception of the GPe in one case, there was significant neuronal loss in all basal ganglia regions in PSP cases compared with controls. With the exception of degeneration in the SNc, there was considerable variability in the degree of neuronal loss within the basal ganglia structures evaluated. Comparison between PSP cases with and without gaze palsy suggests that significant degeneration of the SNr differentiates these cases (asterisks) with an average 40% more cell loss found in the SNr of PSP cases with gaze palsy. Mean and SEM are indicated for each group.
at 200ϫ magnification were found in all cases (Fig. 1) , although
Results
the degree of neurodegeneration varied greatly in this nucleus By definition, all PSP cases had significant subcortical (Fig. 2) . The basal ganglia structure with the most variable neurofibrillary tangle (NFT) and glial pathology with limited density of NFT pathology was the GPe (Table 1 ). The case cortical involvement (Table 1) . As has been previously with the greatest reduction in GPe neurons (case 5, Table 2 ) described (Hauw et al., 1994; Daniel et al., 1995; had the smallest number of NFT in this nucleus (case 5, Table 1 ). et al., 1996; Litvan et al., 1996a; Verny et al., 1996) , the The case without significant degeneration of the globus pallidus pattern of NFT formation in the different basal ganglia or SNr (case 4, Table 2 ) had the greatest density of NFT structures was not consistent across cases (Table 1 ). The pathology (Fig. 1B ) in all basal ganglia regions (case 4, Table pattern of neuronal cell loss also varied considerably across 1). This data suggests that the degree of neurodegeneration the PSP cases (Table 2) , although substantial loss of within the basal ganglia is unrelated to the density of NFT. pigmented SNc neurons was universal (Fig. 2) . The impact Fibrillar pathology was also evident throughout the neuropil of the disease on these basal ganglia structures was greatest in the form of tufted astrocytes, coiled bodies and neuropil in the SNc, followed by the STN, SNr and then the GPi threads ( Fig. 1) , as described previously (Probst et al., 1988;  (Fig. 2) . The GPe was the least affected basal ganglia region Chin and Goldman, 1996; Ikeda et al., 1998) . The density of in all cases with no GPe cell loss in one case ( Fig. 2; Table 2 ).
these fibrillary structures within the basal ganglia appeared No correlation between the degree of neuronal cell loss and proportional to the density of NFTs (Table 1) . the density of NFT could be identified (r Ͻ 0.80, P Ͼ 0.05 for all structures). Within the GPi, more than six NFT per field Four cases had gaze palsy (Table 1) . At the time of death these cases all had moderate to severe limitations in voluntary major output nuclei of the basal ganglia and has two major GABAergic projections: one to the superior colliculus and vertical saccades and pursuit eye movements. The duration of gaze palsy was similar in all cases (Table 1 ). In the other two the other to the motor thalamus (Francois et al., 1984; Tokuno et al., 1993) . The frontal eye fields have a powerful excitatory cases there was no evidence of gaze palsy throughout the course of their disease (cases 4 and 6, Table 1 ). Case 4 (Table 1) had influence on neurons of the superior colliculus both directly and through the basal ganglia (Sharpe, 1998) . GABAergic detailed examinations by a neurologist 1 year after the onset of symptoms as well as 3 years later, 3 months prior to an SNr neurons inhibit saccade burst neurons in the superior colliculus, thereby stabilizing fixation by preventing untimely death during an assault. Case 6 (Table 1) presented 18 months after the onset of symptoms and was examined unwanted extraneous saccades and reflexive saccades (Sharpe, 1998) . GABAergic caudate neurons inhibit SNr neurons with by a neurologist every 2 years. Eight years into the disease, intercurrent ovarian carcinoma was diagnosed. Examination the frontal eye fields exciting the superior colliculus by way of this double inhibition. These visuomotor pathways are by a neurologist revealed normal eye movements at this time. Case 6 died 6 months later from tumour-related complications.
concerned with complex saccadic behaviours, including maintaining fixation, disengaging fixation so that a saccade Severe neurodegeneration of the SNc occurred in all cases (Fig. 2) . In general, neuronal loss within other basal ganglia can be made to a new target, and making saccades to remembered target locations (Goldberg et al., 1991 ; Stell and regions was more marked in the cases with gaze palsy (Fig. 2) . The largest difference between cases with and without gaze Bronstein, 1994; Büttner-Ennever and Horn, 1997; Kawagoe et al., 1998; Sharpe, 1998) . Substantial SNr degeneration as palsy was the loss of SNr neurons (Fig. 2) . The SNr had an average of 75 Ϯ 8% cell loss in cases with gaze palsy compared well as the loss of dopaminergic regulation of the frontal eye field relay through the caudate nucleus would certainly disrupt with only 35 Ϯ 14% cell loss in the cases without. In this region the variation in the degree of cell loss in cases with gaze palsy basal ganglia pathways influencing visuomotor processing in the superior colliculus in PSP. was less than that observed in any other basal ganglia region (Fig. 2) . This is consistent with the limited variation in the Degeneration of basal ganglia structures has not been evaluated in relation to gaze palsy in PSP because of the duration of gaze palsy in these cases. However, the density of NFT was similar in cases with or without gaze palsy (Table 1) considerable emphasis placed on cell loss in other non-basal ganglia brainstem regions (Daniel et al., 1995; Litvan, 1998) . (Daniel et al., 1995) .
While degeneration is maximal within the basal ganglia in PSP, considerable variability in neuronal vulnerability was observed in these structures in the present study (see also
Discussion
This is the first study to evaluate the degree of degeneration Daniel et al., 1995) and evidence for a relationship between a site of basal ganglia degeneration and gaze palsy is across several basal ganglia structures in PSP with respect to associated gaze palsy. Unbiased stereological techniques presented. Only two other research groups have evaluated regional cell loss in relation to gaze palsy: one comparing were used in cases with the typical pathology of PSP (Litvan et al., 1996a) . The number of cases analysed is small due to three, then later four PSP cases with gaze palsy with four controls without neurological impairment (Juncos et al., the low incidence of the disease (1.5-3 cases per million population (Golbe, 1994; Lantos, 1994; Bower et al., 1997 Bower et al., ), 1991 Malessa et al., 1991 Malessa et al., , 1994 and the other comparing eight PSP cases with gaze palsy with five PSP cases without the presence of additional confounding pathologies in a proportion of cases (Gearing et al., 1994; Hauw et al., 1994;  gaze palsy and six controls (Revesz et al., 1996) . The first group used immunohistochemistry to evaluate cell loss Lantos, 1994) and the lack of available tissue for adequate stereological sampling from regions required for the diagnosis (Juncos et al., 1991; Malessa et al., 1991) . However, we have subsequently shown that a reduction in immunohistochemical of the disease (no additional cases are available for serial section analysis of these basal ganglia structures from our markers does not necessarily equate with cell attrition (Hardman et al., , 1997a . Therefore, further work is inquiries to other brain banks). Despite this, with the exception of the work by Revesz and colleagues (Revesz et al., 1996) , required to substantiate the theory that degeneration of the burst neurons in the rostral interstitial nucleus of the medial the number of cases quantitatively analysed in the present study is greater than that reported in the majority of previous longitudinal fasciculus (Juncos et al., 1991) underlies vertical gaze palsy in PSP. publications analysing neuronal degeneration in association with gaze palsy (Juncos et al., 1991; Malessa et al., 1991, The triggering of burst neurons to make saccades is controlled by omnipause neurons in the pontine nucleus 1994). In addition, by sequentially sampling throughout the basal ganglia, biases due to regional concentrations of raphe interpositus (Goldberg et al., 1991; Büttner-Ennever and Horn, 1997) . A detailed study of this region in PSP pathology are eliminated and correction estimates not required. The use of unbiased quantitative methods and strict cases with gaze palsy (Revesz et al., 1996) showed a substantial loss of omnipause neurons (on average 50% loss inclusion criteria has allowed us to make several observations concerning the disease process. compared with controls). This cell loss is highly variable in PSP patients (50 Ϯ 19% loss) and there is considerable Gaze palsy in PSP is associated with substantial degeneration of the GABAergic SNr. The SNr is one of the overlap between the PSP cases with and without gaze palsy (Revesz et al., 1996) . This contrasts with our results in the course of the disease), which is in contrast to NFT in Alzheimer's disease where lesions can be seen for decades, SNr where there is a greater and less variable reduction in neuronal number in PSP cases with gaze palsy (average even after the death of the cell (Braak and Braak, 1998) . This means that the additional evaluation of neuronal loss is 75 Ϯ 8% loss) and no overlap between the degree of cell loss in patients with and without this sign. The degree of required in PSP to determine sites of previous degeneration. As previously noted (Daniel et al., 1995) , the distribution degeneration in the SNr compared with the raphe interpositus supports an important role for the SNr in at least some and density of NFT did not distinguish PSP cases with gaze palsy from those without this sign. PSP cases with gaze palsy. Our thesis is that considerable destruction of any of the neuronal groups involved in
We present novel results supporting a role for degeneration of the SNr in the development of gaze palsy in at least some pathways regulating eye movements are likely to disrupt such behaviours. The more consistent pathological involvement of cases with PSP. The pathological involvement of this basal ganglia structure in many PSP cases suggests that it may be the basal ganglia in PSP patients with gaze palsy leads to greater probability of this region playing a primary role in a widespread phenomenon. We agree with the previous study by Revesz and colleagues, which suggested that careful the generation of this clinical feature. It will be important to examine more PSP cases with and without eye signs to morphometric evaluations of cases with PSP distinguish histological differences that relate to their disease symptoms identify the regions consistently associated with this clinical feature of the disease.
and signs (Revesz et al., 1996) . Thus, the findings presented in the present study add further to our understanding of the Our data also suggest that the STN may contribute to gaze palsy in PSP cases. The STN receives significant afferent morphological basis of eye movement abnormalities in PSP. input from the motor and premotor cortices, including the frontal eye fields and the supplementary eye fields (Künzle and Akert, 1977; Noda and Oka, 1993; Bevan et al., 1995;  of both regions and the same outcome, that is, a decrease in C, et al. Progressive supranuclear palsy: anatomoclinical and the inhibitory output of the SNr. biochemical considerations. Adv Neurol 1987; 45: 191-206. We found that the ranked density of NFT pathology does Bevan MD, Francis CM, Bolam JP. The glutamate-enriched cortical not correlate with the degree of neuronal loss within the and thalamic input to neurons in the subthalamic nucleus of the rat: basal ganglia in PSP (see also Agid et al., 1987) . This convergence with GABA-positive terminals. J Comp Neurol 1995;  contrasts with previous findings comparing neuronal and 361: 491-511.
NFT densities directly (Lantos, 1994; Revesz et al., 1996) .
Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence A close relationship between these variables could suggest of progressive supranuclear palsy and multiple system atrophy in ongoing neurodegeneration at the time of evaluation. If so, Olmsted County, Minnesota, 1976 to 1990 . Neurology 1997 49: the reported data suggest that there is ongoing degeneration 1284-8. in the raphe interpositus at the time of death (Revesz et al., Braak H, Braak E. Neuropathological staging of Alzheimer-related 1996) but more variable involvement within the basal ganglia changes. [Review] . Acta Neuropathol (Berl) 1991; 82: 239-59. structures (present study) . Surprisingly, our data show that the density of NFT pathology was lowest in regions with the Braak H, Braak E. Evolution of neuronal changes in the course of greatest neuronal loss (e.g. the dopaminergic SNc) and in Alzheimer's disease. [Review] . J Neural Transm 1998; Suppl 53: 127-40. cases with the longest duration (case 5, Table 1 ). In contrast, NFT formation was greatest in cases with the most limited 
